Recent research suggests that Viagra, a drug primarily used to treat erectile dysfunction, may offer benefits for cancer patients. Originally developed to address high blood pressure and chest pain, its unexpected effect on erectile function was discovered during clinical trials.

Study Findings

A study published by the American Association for Cancer Research indicates that Viagra’s active ingredient, sildenafil, a PDE5 inhibitor, may help prevent cancer from spreading. Researchers at the Weizmann Institute of Science in Israel, led by Dr. Yarden Ariav, found that sildenafil may restrict cancer metastasis, or the formation of new tumors.

The research involved collaboration with the U.S. National Cancer Institute. It included analyses of human and mouse cancer cells, genetic experiments, and 20 years of health data from 5 million members of Clalit Health Services, Israel’s largest nonprofit healthcare provider. The study discovered how genes, proteins, fats, cholesterol, and cellular energy interact.

Sildenafil limits a cancer cell’s ability to utilize cholesterol, an essential mechanism for cell migration from the primary tumor.

Mechanism of Action

Sildenafil blocks phosphodiesterase type 5 (PDE5) and increases the signaling molecule cGMP, which dilates blood vessels, explaining its success as a treatment for erectile dysfunction.

The researchers found that cGMP binds to a protein that transports cholesterol within cells, reducing available cholesterol for essential cellular functions. Cancer cells are vulnerable to this reduced cholesterol supply, which hinders their ability to spread.

Therapeutic Potential

Based on these findings, the researchers suggest combining Viagra-related drugs with statins, which lower cholesterol levels, could decelerate cancer spread by reducing tumor cells’ access to cholesterol.

“We have uncovered a new biological pathway linking a well-known signaling molecule to cholesterol regulation… this pathway can interfere with cancer cells’ ability to form metastases,” commented Professor Ayelet Erez.

Considerations and Implications

The study used mouse models, which may limit implications, as cancer treatments don’t always translate similarly to humans. The human evidence is observational, showing an association instead of a cause and effect.

Acknowledging these results, the researchers emphasized the importance of treating the entire patient, not solely the cancer, to maximize therapy effectiveness.